Results 61 to 70 of about 5,988 (201)

Whole‐Body CT Utilisation in Adult Trauma: Guideline Compliance, Incidental Findings, and the Role of Anticoagulation in Low‐Energy Falls at a Regional New Zealand Centre

Journal of Medical Imaging and Radiation Oncology, EarlyView.
ABSTRACT Introduction Whole‐body CT (WBCT) is central to major trauma assessment, but indiscriminate use carries a substantial radiation burden. The Central Region Trauma Network's Early Radiological Imaging in Major Trauma Guideline (CPG154), adopted at this centre, specifies criteria for WBCT and excludes low‐energy falls from standing height.
Vamsi Thammandra, Jonny Russell
wiley   +1 more source

Equivalence of DOACS and LMWH for thromboprophylaxis after hip fracture surgery: Systematic review and meta-analysis

, 2022
Background: Patients with hip fractures (HF) have an increased risk of venous thromboembolism (VTE). In elective orthopedic surgery direct oral anticoagulants (DOACs) have proven to be similarly or more effective compared to low molecular weight heparin (
Bijman, Q., Schipper, I.B., Nederpelt, C.J., Krijnen, P., Pieta Krijnen, Charlie J. Nederpelt, Inger B. Schipper, Quinten Bijman   +7 more
core   +1 more source

Cross‐Sectional Study of the PREValence of Erectile DysfunctIon in the Arteriopathic Population (PREVEDI)

Andrology, EarlyView.
ABSTRACT Background Although the association between erectile dysfunction (ED) and cardiovascular disease is well established, its prevalence in patients with atherosclerosis remains poorly defined. Objectives To evaluate ED prevalence, severity, and associated risk factors (RFs) in patients with atherosclerotic disease.
Luca Farchioni, Andrea Ferri, Nicola Leone, Mattia Migliari, Luigi Alberto Maria Bartolotti, Daniele Santi, Giorgia Spaggiari, Roberto Silingardi, Stefano Gennai   +8 more
wiley   +1 more source

Clinical pearls:Laboratory assessments of direct oral anticoagulants (DOACS)

, 2017
Summary Direct oral anticoagulants (DOACS) are being used for stroke prevention in patients with atrial fibrillation as well as for prophylaxis and treatment of venous thromboembolism.
Adcock, Dorothy, Jonathan Douxfils, Robert Gosselin, Dorothy Adcock, Gosselin, Robert, Douxfils, Jonathan; id_orcid   +5 more
core   +1 more source

Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants [version 1; referees: 2 approved]

F1000Research, 2017
The direct oral anticoagulants (DOACs) have now supplanted vitamin K antagonists (VKAs) for the treatment of venous thromboembolism (VTE). The DOACs include dabigatran, which inhibits thrombin, and rivaroxaban, apixaban, and edoxaban, which inhibit ...
Jeffrey I. Weitz, Iqbal H. Jaffer, James C. Fredenburgh   +2 more
doaj   +1 more source

DOACs – advances and limitations in real world [PDF]

Thrombosis Journal, 2016
The group of new oral anticoagulants or NOACs, now termed direct oral anticoagulants or DOACs, with their favourable results from large scale phase III clinical trials, represent a major advancement and expanded armamentarium in antithrombotic therapy.
openaire   +2 more sources

Pulmonary Embolism—A Century of Progress

ANZ Journal of Surgery, EarlyView.
Reviews a century of progress in the diagnosis, prevention, and management of pulmonary embolism; from the first successful surgical embolectomy in 1924 to advanced imaging, pharmacological thromboprophylaxis, and treatment. In the 21st century, advances include catheter‐directed thrombolysis or mechanical thrombectomy under decision‐making guidance of
D. A. Watters
wiley   +1 more source

Pleiotropic properties of direct oral anticoagulants — new therapeutic horizons

Рациональная фармакотерапия в кардиологии
Direct oral anticoagulants (DOACs), including factor Xa inhibitors (rivaroxaban, apixaban, edoxaban) and the direct thrombin inhibitor dabigatran, are widely used for the prevention and treatment of thrombotic complications, particularly in patients ...
P. A. Davtian, N. S. Zagidullin
doaj   +1 more source

Evaluation of the DOAC-Stop® Procedure to Overcome the Effect of DOACs on Several Thrombophilia Screening Tests [PDF]

TH Open, 2018
AbstractThe impact of direct oral anticoagulants (DOACs) on laboratory assays used for thrombophilia testing (e.g., antithrombin, protein S, protein C, lupus anticoagulant and activated protein-C resistance) is a well-known issue and may cause false-positive and -negative results.
Favresse, Julien, Lardinois, Benjamin, Sabor, Lina, Devalet, Bérangère, Vandepapeliere, Julie, Braibant, Maximilien, Lessire, Sarah, Chatelain, Bernard, Jacqmin, Hugues, Douxfils, Jonathan; id_orcid 0000-0002-7644-5298, Mullier, François   +10 more
openaire   +4 more sources

Beyond Anticoagulant Exposure: Determinants of Mortality After Gastrointestinal Bleeding Across DOAC, Warfarin and Non‐Anticoagulated Patients

Alimentary Pharmacology &Therapeutics, EarlyView.
Among 11,387 patients with acute gastrointestinal bleeding, overlap‐weighted analyses (n = 10,044) found no statistically significant association between direct oral anticoagulant or warfarin use and 30‐day or 1‐year mortality. Haemodynamic shock was associated with 30‐day mortality, whereas age and Internal Medicine ward admission were associated with
Esther Forkosh, David Hakimian, Harold Jacob, Ian M. Gralnek, Lior Katz, Aviv Talmon   +5 more
wiley   +1 more source